Lymphoma Clinical Trials

Showing 621-640 of 1,633 trials

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

NCT03422679

This is a phase I/II, non randomized, open-label, dose escalation study to investigate the safety, tolerability and preliminary efficacy of CB-103.

Breast CancerColorectal CancerAdenoid Cystic Carcinoma+5 more

Cellestia Biotech AG79 participantsStarted Dec 2017

Santa Monica, California, United States • Boston, Massachusetts, United States • Houston, Texas, United States +14 more locations

UNKNOWN

CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy

NCT06202885

The goal of this retrospective study is to compare between the case cohort and control cohort. The case cohort consists of lymphoma patients treated with novel immunotherapy regimen including Chimeric antigen receptor T cell therapy, bispecfic antibody, and/or antibody-drug conjugate. The control cohort consists of lymphoma patients who received conventional chemotherapy as standard-of-care The main question\[s\] it aims to answer are: * Survival times * Response outcomes

Lymphoma

Seoul St. Mary's Hospital2,500 participantsStarted Oct 2023

Seoul, South Korea

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy

Related Searches

BV-AVD-R Treatment Children Hodgkin's Lymphoma

Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Precision Exercise in Children With Malignant Hemopathies

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's Lymphoma

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

Danish Elder Lymphoma Patient Hematopoietic Investigation

Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma

Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study

Idiotype Vaccine After Chemotherapy & Stem Cell Transplantation in Lymphoma With Failed Induction Chemotherapy

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma

PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage IA or Stage IIA Hodgkin Lymphoma

A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational)

Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma

Patient Reported Outcomes and Patient Education in Cellular Therapy Patients

Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies